ATR vs TRS
ATR: AptarGroup is a global leader in drug delivery and consumer product dispensing solutions, providing specialized pumps, valves, and packaging for pharmaceutical and consumer goods markets. TRS: TriMas is a diversified global manufacturer of highly engineered packaging and specialty industrial components.
Side-by-side fundamentals
| Metric | ATR | TRS | Edge |
|---|---|---|---|
| Price as of 2026-10-20 close | $125.77 | $39.70 | |
| Market cap | $8.0B | $1.4B | |
| P/E as of 2026-10-20 | 22.70 | 1.64 | TRS lower |
| PEG as of 2026-10-20, 3-year EPS CAGR to FY2025 | 1.27 | n/a | |
| Net margin FY2025, SEC XBRL | +10.4% | +18.6% | TRS higher |
| Gross margin FY2025, SEC XBRL | n/a | +21.4% | |
| Operating margin FY2025, SEC XBRL | +13.3% | +6.4% | ATR higher |
| ROE FY2025, SEC XBRL | +14.6% | +17.0% | TRS higher |
| ROA FY2025, SEC XBRL | +7.5% | +8.1% | TRS higher |
| Debt / equity filed borrowings incl. finance leases, balance sheet 2026-06-30 | 0.52 | 0.28 | TRS lower |
| Revenue growth (YoY) FY2025, SEC XBRL | +5.4% | +2.4% | ATR higher |
| Revenue CAGR (3y) SEC XBRL | +4.4% | -9.9% | ATR higher |
| Dividend yield as of 2026-09-03 | +1.5% | +0.4% | ATR higher |
| Dividend streak (yrs) SEC XBRL | 7 | 5 | ATR higher |
| Beta as of 2026-09-03 | 0.58 | 0.83 | |
| 1-year return as of 2026-10-20 close | -3.3% | +4.9% | TRS higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-20.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.